Syndax Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Syndax Pharmaceuticals Inc
CIK #0001395937
EDGAR Form CIK 2011 - 2026
10-K [0001395937]
10-Q [0001395937]
3 [0001395937]
4 [0001395937]
8-K [0001395937]
D [0001395937]
SC 13D [0001395937]
SC 13G [0001395937]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Syndax Pharmaceuticals Inc [2026-04-30]
State Street Corp Syndax Pharmaceuticals Inc [2026-02-09]
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-08-18]
Goldman Sachs Group Inc Syndax Pharmaceuticals Inc [2025-02-12]
Morgan Stanley Syndax Pharmaceuticals Inc [2025-02-05]
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2025-01-22]
Kynam Capital Management LP Syndax Pharmaceuticals Inc [2024-02-14]
Vanguard Group Inc Syndax Pharmaceuticals Inc [2024-02-13]
Point72 Asset Management LP Syndax Pharmaceuticals Inc [2023-10-31]
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2023-01-10]
Nantahala Capital Management LLC Syndax Pharmaceuticals Inc [2022-02-14]
Frazier Life Sciences Public Fund LP Syndax Pharmaceuticals Inc [2021-12-23]
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2021-05-10]
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2021-05-03]
BlackRock Inc Syndax Pharmaceuticals Inc [2021-02-02]
Avidity Partners Management LP Syndax Pharmaceuticals Inc [2020-11-04]
Boxer Capital LLC Syndax Pharmaceuticals Inc [2020-05-11]
Access Industries Holdings LLC Syndax Pharmaceuticals Inc [2019-10-09]
Adage Capital Partners GP LLC Syndax Pharmaceuticals Inc [2019-04-08]
BlackRock Inc Syndax Pharmaceuticals Inc [2019-02-08]
683 Capital Management LLC Syndax Pharmaceuticals Inc [2018-11-29]
Biotechnology Value Fund L P Syndax Pharmaceuticals Inc [2017-11-14]
MPM BioVentures IV QP LP Syndax Pharmaceuticals Inc [2017-02-09]
BlackRock Inc Syndax Pharmaceuticals Inc [2017-01-30]
Domain Partners VIII LP Syndax Pharmaceuticals Inc [2017-01-09]
Wellington Management Group LLP Syndax Pharmaceuticals Inc [2016-09-12]
FMR LLC Syndax Pharmaceuticals Inc [2016-04-11]
Form 3/4/5 Subject 2011 - 2026
Syndax Pharmaceuticals Inc
Botwood Nicholas AJ
Metzger Michael A
Goldan Keith A
Podlesak Dennis
Rizo Aleksandra
Jarrett Jennifer
Huber Martin H Jr
Katkin Keith
Legault Pierre
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-09 Sell 17,159 $21.03 360,854
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-09 Sell 3,410 $21.03 71,712
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-06 Sell 2,082 $20.62 42,931
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-06 Sell 7,412 $20.62 152,835
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 48,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 73,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 21,500 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 144,600 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 36,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 30,750 $0.00
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
2026-02-04 Grant 144,700 $20.43 2,956,221
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
2026-02-04 Grant 118,000 $20.43 2,410,740
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
2026-02-04 Grant 440,000 $20.43 8,989,200
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-02-04 Grant 24,000 $0.00
Syndax Pharmaceuticals Inc SNDX
Common Stock
2026-01-30 Other 1,219 $8.48 10,337
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com